Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-18

Clinical Trial Update: Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the role of psilocybin monitors in psilocybin-assisted therapy for treatment-resistant depression; the study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Treatment-Resistant Depression | Phase 2 | Status: NOT_YET_RECRUITING